<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-3-4.anc" start="20731" end="20736" sStart="-1" offset="0" sid="null" wn="5" wnkey="write%2:36:01::" annotator="veweser" text="More formally we can &lt;b&gt;write&lt;/b&gt; the reduction in population cancer mortality rates associated with starting periodic cancer screening at age a instead of age b as" />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-3-4.anc" start="39584" end="39589" sStart="null" offset="0" sid="null" wn="2" wnkey="write%2:32:00::" annotator="tofox" text="SGB &lt;b&gt;wrote&lt;/b&gt; the initial draft." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-3-4.anc" start="20731" end="20736" sStart="null" offset="0" sid="null" wn="5" wnkey="write%2:36:01::" annotator="jeneale" text="More formally we can &lt;b&gt;write&lt;/b&gt; the reduction in population cancer mortality rates associated with starting periodic cancer screening at age a instead of age b as" />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-3-4.anc" start="20731" end="20736" sStart="null" offset="0" sid="null" wn="7" wnkey="write%2:36:03::" annotator="carichter" text="More formally we can &lt;b&gt;write&lt;/b&gt; the reduction in population cancer mortality rates associated with starting periodic cancer screening at age a instead of age b as" />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-3-4.anc" start="8202" end="8208" sStart="null" offset="0" sid="null" wn="5" wnkey="window%1:28:00::" annotator="veweser" text="The length of the &lt;b&gt;window&lt;/b&gt; for on-time screenings is somewhat arbitrary." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-3-4.anc" start="8515" end="8521" sStart="null" offset="0" sid="null" wn="5" wnkey="window%1:28:00::" annotator="veweser" text="Alternatively, a narrow &lt;b&gt;window&lt;/b&gt; might discard too much data, increasing the chance for bias from nonrandom exclusion of subjects." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-3-4.anc" start="8202" end="8208" sStart="null" offset="0" sid="null" wn="5" wnkey="window%1:28:00::" annotator="veweser" text="The length of the &lt;b&gt;window&lt;/b&gt; for on-time screenings is somewhat arbitrary." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-3-4.anc" start="8202" end="8208" sStart="null" offset="0" sid="null" wn="5" wnkey="window%1:28:00::" annotator="jeneale" text="The length of the &lt;b&gt;window&lt;/b&gt; for on-time screenings is somewhat arbitrary." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-3-4.anc" start="28638" end="28644" sStart="null" offset="0" sid="null" wn="5" wnkey="window%1:28:00::" annotator="cgozo" text="(The longer time &lt;b&gt;window&lt;/b&gt; was used to keep the loss of data arbitrarily to no more than 15%) Excluding the first screening after the resumption of screening, approximately 93 percent of the annual subsequent screenings and 85 percent of the biennial subsequent screenings were on-time." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-3-4.anc" start="8473" end="8479" sStart="null" offset="0" sid="null" wn="4" wnkey="window%1:17:00::" annotator="brubin" text="A very wide &lt;b&gt;window&lt;/b&gt; discards relatively few subjects; however it may introduce bias into calculations that are based on assuming the screening interval equals the midpoint of the &lt;b&gt;window&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-3-4.anc" start="8202" end="8208" sStart="null" offset="0" sid="null" wn="4" wnkey="window%1:17:00::" annotator="brubin" text="The length of the &lt;b&gt;window&lt;/b&gt; for on-time screenings is somewhat arbitrary." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-3-4.anc" start="8277" end="8283" sStart="null" offset="0" sid="null" wn="4" wnkey="window%1:17:00::" annotator="brubin" text="A very wide &lt;b&gt;window&lt;/b&gt; discards relatively few subjects; however it may introduce bias into calculations that are based on assuming the screening interval equals the midpoint of the &lt;b&gt;window&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-3-4.anc" start="8202" end="8208" sStart="null" offset="0" sid="null" wn="5" wnkey="window%1:28:00::" annotator="a4" text="The length of the &lt;b&gt;window&lt;/b&gt; for on-time screenings is somewhat arbitrary." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-3-4.anc" start="8202" end="8208" sStart="null" offset="0" sid="null" wn="5" wnkey="window%1:28:00::" annotator="a3" text="The length of the &lt;b&gt;window&lt;/b&gt; for on-time screenings is somewhat arbitrary." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-3-4.anc" start="8202" end="8208" sStart="null" offset="0" sid="null" wn="5" wnkey="window%1:28:00::" annotator="a2" text="The length of the &lt;b&gt;window&lt;/b&gt; for on-time screenings is somewhat arbitrary." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-3-4.anc" start="8202" end="8208" sStart="null" offset="0" sid="null" wn="5" wnkey="window%1:28:00::" annotator="a1" text="The length of the &lt;b&gt;window&lt;/b&gt; for on-time screenings is somewhat arbitrary." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-3-4.anc" start="17884" end="17889" sStart="null" offset="215" sid="r7.1.use.v.0850" wn="1" wnkey="use%2:34:01::" annotator="jeneale" text="As an alternative, we estimate an upper bound on the reduction in the population cancer mortality rate from screening by estimating the cancer fatality rate in the absence of screening using data from interval cancers, namely, substituting m " />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-3-4.anc" start="39238" end="39242" sStart="null" offset="175" sid="r11.true.j.0195" wn="5" wnkey="true%5:00:00:typical:00" annotator="adelpriore" text="Because PSE is estimating an upper bound when Assumption 1 is violated, if PSE estimates little reduction in population cancer mortality, the true reduction in population cancer mortality due to periodic screening is likely small." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2288-3-4.anc" start="30505" end="30509" sStart="null" offset="0" sid="null" wn="1" wnkey="time%1:11:00::" annotator="carichter" text="For estimating the age-specific incidence of cancer among controls, we used data collected up to the &lt;b&gt;time&lt;/b&gt; of the last screen, which was 4 years after the start of the study." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-3-4.anc" start="17547" end="17553" sStart="null" offset="0" sid="r11.strong.j.0602" wn="" wnkey="null" annotator="anfahmy" text="" />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-3-4.anc" start="38789" end="38793" sStart="null" offset="37" sid="r1.rule.v.0096" wn="2147483647" wnkey="null" annotator="sophiavv" text="We think the major role of PSE is to rule out screening modalities that have little benefit." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-3-4.anc" start="38789" end="38793" sStart="null" offset="37" sid="r1.rule.v.0096" wn="2147483647" wnkey="null" annotator="anfahmy" text="We think the major role of PSE is to rule out screening modalities that have little benefit." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-3-4.anc" start="38789" end="38793" sStart="null" offset="37" sid="r1.rule.v.0096" wn="2147483647" wnkey="null" annotator="adelpriore" text="We think the major role of PSE is to rule out screening modalities that have little benefit." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-3-4.anc" start="21893" end="21899" sStart="null" offset="26" sid="r11.refer.v.0701" wn="2" wnkey="refer%2:42:00::" annotator="anfahmy" text="and cancer death in cases refers to death from cancer in cases within five years of cancer detection." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-3-4.anc" start="19341" end="19346" sStart="null" offset="0" sid="null" wn="4" wnkey="rate%1:24:00::" annotator="cgozo" text="PSE estimates the reduction in population cancer mortality &lt;b&gt;rates&lt;/b&gt; due to starting periodic cancer screening at age a instead of age b , where ages a and b lie in the range of ages at initial screening." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-3-4.anc" start="19341" end="19346" sStart="null" offset="0" sid="null" wn="4" wnkey="rate%1:24:00::" annotator="brubin" text="PSE estimates the reduction in population cancer mortality &lt;b&gt;rates&lt;/b&gt; due to starting periodic cancer screening at age a instead of age b , where ages a and b lie in the range of ages at initial screening." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-3-4.anc" start="32370" end="32377" sStart="null" offset="166" sid="r10.control.n.0343" wn="4" wnkey="control%1:09:02::" annotator="cgozo" text="Unfortunately the initial screening in the control group greatly complicated the validation, which requires that no screening be performed in the control group." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-3-4.anc" start="7731" end="7739" sStart="null" offset="0" sid="r10.control.n.0394" wn="4" wnkey="control%1:09:02::" annotator="anfahmy" text="controls, if available, (2) estimate cancer fatality rates after cancer detection, and (3) combine these estimates to estimate the reduction in population cancer mortality associated with periodic cancer screening." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-3-4.anc" start="5008" end="5019" sStart="null" offset="17" sid="r11.combination.n.0592" wn="1" wnkey="combination%1:14:00::" annotator="vebatchelder" text="The longitudinal combination of cross-sectional estimates, which also appears in earlier versions of PSE [ 7 8 9 ] , is similar to G-computation [ 10 ] and the method of Flanders and Longini [ 11 ] ." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-3-4.anc" start="25878" end="25884" sStart="null" offset="0" sid="null" wn="" wnkey="null" annotator="tofox" text="For example if the screening test were based on a sampling of cells, the screening test may, by &lt;b&gt;chance&lt;/b&gt;, not include any of the tumor cells." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-3-4.anc" start="8576" end="8582" sStart="null" offset="0" sid="null" wn="" wnkey="null" annotator="tofox" text="Alternatively, a narrow window might discard too much data, increasing the &lt;b&gt;chance&lt;/b&gt; for bias from nonrandom exclusion of subjects." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-3-4.anc" start="25878" end="25884" sStart="null" offset="0" sid="null" wn="2" wnkey="chance%1:19:00::" annotator="comcgeetubb" text="For example if the screening test were based on a sampling of cells, the screening test may, by &lt;b&gt;chance&lt;/b&gt;, not include any of the tumor cells." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-3-4.anc" start="8576" end="8582" sStart="null" offset="0" sid="null" wn="4" wnkey="chance%1:07:00::" annotator="comcgeetubb" text="Alternatively, a narrow window might discard too much data, increasing the &lt;b&gt;chance&lt;/b&gt; for bias from nonrandom exclusion of subjects." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-3-4.anc" start="25878" end="25884" sStart="null" offset="0" sid="null" wn="" wnkey="null" annotator="chisom" text="For example if the screening test were based on a sampling of cells, the screening test may, by &lt;b&gt;chance&lt;/b&gt;, not include any of the tumor cells." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2288-3-4.anc" start="8576" end="8582" sStart="null" offset="0" sid="null" wn="" wnkey="null" annotator="chisom" text="Alternatively, a narrow window might discard too much data, increasing the &lt;b&gt;chance&lt;/b&gt; for bias from nonrandom exclusion of subjects." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-3-4.anc" start="5998" end="6005" sStart="null" offset="498" sid="null" wn="1" wnkey="absence%1:26:00::" annotator="vebatchelder" text="To determine if the upper bound is reasonable, we estimated its value using data from screened subjects in randomized trials of colorectal cancer screening [ 12 13 ] , breast cancer screening [ 14 ] , and lung cancer screening [ 15 16 ] . We then compared this estimate to a modified PSE estimate using data from all subjects, so that estimates of age-specific cancer detection in the absence of screening and cancer mortality in the absence of screening are based on data from randomized controls and refusers." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-3-4.anc" start="18646" end="18653" sStart="null" offset="244" sid="r11.absence.n.0862" wn="1" wnkey="absence%1:26:00::" annotator="vebatchelder" text="The latter cases are presumably slower growing (a type of length-biased sampling) with better survival, so using only the interval cancers artificially increases the estimated cancer-fatality rate in the absence of screening." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-3-4.anc" start="2426" end="2433" sStart="null" offset="118" sid="r11.absence.n.0778" wn="1" wnkey="absence%1:26:00::" annotator="vebatchelder" text="For evaluation it is also necessary to estimate (1) the age-specific rate of cancer detection in the absence of screening and (2) the cancer mortality rate following detection in the absence of screening." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-3-4.anc" start="32732" end="32739" sStart="null" offset="174" sid="r11.absence.n.0730" wn="1" wnkey="absence%1:26:00::" annotator="vebatchelder" text="The underlying assumption is that by 6 years, most cancers detected on the prevalence screening would have progressed to clinical cancer in the absence of intervention." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-3-4.anc" start="26461" end="26468" sStart="null" offset="0" sid="r11.absence.n.0274" wn="2147483644" wnkey="null" annotator="vebatchelder" text="" />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-3-4.anc" start="5998" end="6005" sStart="null" offset="498" sid="null" wn="1" wnkey="absence%1:26:00::" annotator="anfahmy" text="To determine if the upper bound is reasonable, we estimated its value using data from screened subjects in randomized trials of colorectal cancer screening [ 12 13 ] , breast cancer screening [ 14 ] , and lung cancer screening [ 15 16 ] . We then compared this estimate to a modified PSE estimate using data from all subjects, so that estimates of age-specific cancer detection in the absence of screening and cancer mortality in the absence of screening are based on data from randomized controls and refusers." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-3-4.anc" start="5941" end="5948" sStart="null" offset="441" sid="r11.absence.n.0890" wn="1" wnkey="absence%1:26:00::" annotator="anfahmy" text="To determine if the upper bound is reasonable, we estimated its value using data from screened subjects in randomized trials of colorectal cancer screening [ 12 13 ] , breast cancer screening [ 14 ] , and lung cancer screening [ 15 16 ] . We then compared this estimate to a modified PSE estimate using data from all subjects, so that estimates of age-specific cancer detection in the absence of screening and cancer mortality in the absence of screening are based on data from randomized controls and refusers." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-3-4.anc" start="2942" end="2949" sStart="null" offset="83" sid="r11.absence.n.0878" wn="1" wnkey="absence%1:26:00::" annotator="anfahmy" text="As will be discussed, PSE estimates the age-specific detection rate in the absence of screening as the sum of the age-specific rates of detection for cancers on the first screening, interval cancers, and cancers on subsequent screenings, minus the age-specific rate of detection for cancer on the first screening in subjects one year older." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-3-4.anc" start="5998" end="6005" sStart="null" offset="498" sid="r11.absence.n.0794" wn="1" wnkey="absence%1:26:00::" annotator="anfahmy" text="To determine if the upper bound is reasonable, we estimated its value using data from screened subjects in randomized trials of colorectal cancer screening [ 12 13 ] , breast cancer screening [ 14 ] , and lung cancer screening [ 15 16 ] . We then compared this estimate to a modified PSE estimate using data from all subjects, so that estimates of age-specific cancer detection in the absence of screening and cancer mortality in the absence of screening are based on data from randomized controls and refusers." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-3-4.anc" start="4129" end="4136" sStart="null" offset="153" sid="r11.absence.n.0374" wn="1" wnkey="absence%1:26:00::" annotator="anfahmy" text="To avoid this assumption (and the need to collect data from refusers), we estimated the cancer mortality rate following detection in the absence of screening by the cancer mortality rate in interval cancers." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-3-4.anc" start="9345" end="9352" sStart="null" offset="380" sid="r11.absence.n.0113" wn="1" wnkey="absence%1:26:00::" annotator="anfahmy" text="PSE requires estimates of age-specific cancer incidence for the following types of cancer detection: type F , detection on the first screening; type I , detection in the interval between screenings; type S , detection on screening subsequent to the first; and type A , detection in the absence of screening." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-3-4.anc" start="5998" end="6005" sStart="null" offset="498" sid="null" wn="1" wnkey="absence%1:26:00::" annotator="adelpriore" text="To determine if the upper bound is reasonable, we estimated its value using data from screened subjects in randomized trials of colorectal cancer screening [ 12 13 ] , breast cancer screening [ 14 ] , and lung cancer screening [ 15 16 ] . We then compared this estimate to a modified PSE estimate using data from all subjects, so that estimates of age-specific cancer detection in the absence of screening and cancer mortality in the absence of screening are based on data from randomized controls and refusers." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-3-4.anc" start="3676" end="3683" sStart="null" offset="110" sid="r11.absence.n.0918" wn="1" wnkey="absence%1:26:00::" annotator="adelpriore" text="Fortunately, as we discuss, if progressive detection is violated, the estimated detection rate in the absence of screening is an upper bound and this can lead to useful estimates." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-3-4.anc" start="26135" end="26142" sStart="null" offset="125" sid="r11.absence.n.0816" wn="1" wnkey="absence%1:26:00::" annotator="adelpriore" text="As shown in Figure 1, if Assumption 1 did not hold, PSE would estimate the cancer incidence rate in the absence of screening as q " />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-3-4.anc" start="27257" end="27264" sStart="null" offset="112" sid="r11.absence.n.0603" wn="1" wnkey="absence%1:26:00::" annotator="adelpriore" text="First it uses interval cancers to estimate fatality rates following cancer diagnosis in the absence of screening." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2288-3-4.anc" start="17863" end="17870" sStart="null" offset="194" sid="r11.absence.n.0207" wn="1" wnkey="absence%1:26:00::" annotator="adelpriore" text="As an alternative, we estimate an upper bound on the reduction in the population cancer mortality rate from screening by estimating the cancer fatality rate in the absence of screening using data from interval cancers, namely, substituting m " />
  </sentences>
</list>